Navigation Links
Cadence Pharmaceuticals Comments on USPTO's Non-Final, Initial Office Action on Reexamination of Patent
Date:8/15/2013

patent are appropriate and that the USPTO's prior issuance of the patent was correct, the company's plans to continue the reexamination and file additional claims, and Cadence's ability to make a strong case in favor of the patentability of the rejected claims. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Cadence's actual future results may differ materially from the company's current expectations due to the risks and uncertainties inherent in its business. These risks include, but are not limited to: Cadence's dependence on the successful commercialization of OFIRMEV, which is the company's only product; Cadence's ability to achieve broad market acceptance and generate revenues from sales of OFIRMEV; Cadence's ability to successfully enforce its marketing exclusivities and intellectual property rights, and to defend the patents covering OFIRMEV, including in current intellectual property litigation with the parties that have submitted new drug applications ("NDAs") or abbreviated new drug applications ("ANDAs") for generic versions of OFIRMEV; the potential that Cadence may be required to continue intellectual property litigation for substantial lengths of time or file additional lawsuits to defend its patent rights from challenges by companies that have submitted NDAs or ANDAs for generic versions of OFIRMEV, and the substantial costs associated with such lawsuits; the potential introduction of generic competition to OFIRMEV in the event Cadence is unsuccessful in current or future intellectual property litigation, and the impact it may have on the sales and pricing of the product; Cadence's dependence on its licensors for the maintenance and enforcement of its intellectual property rights; the potential product liability exposure associated with pharmaceutical products such as OFIRMEV and other products Cadence may in-license or acquire; Cadence's ability to fully comply with numerous f
'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cadence Pharmaceuticals Appoints Laureen DeBuono to its Board of Directors
2. Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013
3. Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
4. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2013 Financial Results On July 31, 2013
5. Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013
6. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013
7. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
8. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results
9. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Full Year 2012 Financial Results On March 7, 2013
10. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Cowen & Company 33rd Annual Health Care Conference In Boston On March 5, 2013
11. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Leerink Swann Global Healthcare Conference In New York City On February 13, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... The American Association for Homecare (AAHomecare) is ... has joined the AAHomecare Corporate Partner Program. ... have been actively involved in AAHomecare for much of ... grown into a major global manufacturer of home medical ... to increase efforts on behalf of the HME sector ...
(Date:9/19/2014)... 2014 UBM Medica US announces that  ... to help oncologists and other clinicians gain a better ... of targeted therapies and immunotherapies, discusses some of the ... Every September, Blood Cancer Awareness Month ... about blood cancers—helping to increase survival rates and improve ...
(Date:9/19/2014)... -- Larry J. Merlo , President and CEO of ... the National Press Club in Washington, D.C. ... stop selling tobacco products and its leadership in driving the ... "Dramatic changes in our health care system pose enormous challenges ... said. "CVS Health has a truly unique combination of business ...
Breaking Medicine Technology:Drive Medical Design & Manufacturing Joins AAHomecare Corporate Partner Program 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3
... Savient Pharmaceuticals, Inc. (NASDAQ: SVNT ) today reported ... 30, 2011, which reflect the Company,s continuing investment in the ... $202.7 million in cash and short-term investments, a decrease of ... 2011, the Company had a net loss of $27.4 million, ...
... The American College of Emergency Physicians, a national sponsor ... public about safe disposal of expired, unused and unwanted ... abuse or accidental overdose.  A recent study reports that ... deaths in 2008, more than half of the total ...
Cached Medicine Technology:Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 2Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 3Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 4Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 5Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 6Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results 7Emergency Physicians Tell the Public,''Get Rid of Your Stash'' of Unwanted Meds on November 12th 2
(Date:9/19/2014)... Jacksonville,s campus of Mayo Clinic have discovered a defect ... both overproduction of toxic protein in the brains of ... of communication between neurons both significant contributors to ... online issue of Neuron , offers ... "may rejuvenate or rescue this pathway," says the study,s ...
(Date:9/19/2014)... September 19, 2014 Recently, Top10BestSEOHosting.com ... announced that JustHost, IX Web Hosting and Bluehost ... , “As is known to most people, VPS ... a physical server computer into many servers, each ... running on someone’s own dedicated computer,” the manager ...
(Date:9/19/2014)... 2014 BCC Research reveals in its ... MARKETS , the global market for human antifungal therapeutics ... 2018, with a five-year compound annual growth rate (CAGR) ... at a steady 3.8% CAGR. , Given the current ... coupled with the incidence of increasing mortality and the ...
(Date:9/19/2014)... advanced, incurable cancer do not receive any palliative care, ... at the ESMO 2014 Congress in Madrid, Spain, 26-30 ... the same time as 15 new oncology centres in ... the prestigious title of ,ESMO Designated Centre of Integrated ... Grigorescu, medical oncology consultant at the Institute of Oncology ...
(Date:9/19/2014)... Dallas, TX (PRWEB) September 19, 2014 ... which introduces a traditional Scandinavian style of ... United States. Much like Diet Doc’s medical ... Diet emphasizes cooking and eating good food ... diet also focuses on teaching patients to ...
Breaking Medicine News(10 mins):Health News:Mayo researchers reveal pathway that contributes to Alzheimer's disease 2Health News:Top10BestSEOHosting.com: JustHost is One of the Best VPS Suppliers in 2014 2Health News:Global Market for Human Antifungal Therapeutics to Reach Nearly $13.9 Billion in 2018; Over-The-Counter (OTC) Segment Growing At 3.8% CAGR 2Health News:Global Market for Human Antifungal Therapeutics to Reach Nearly $13.9 Billion in 2018; Over-The-Counter (OTC) Segment Growing At 3.8% CAGR 3Health News:Patients with advanced, incurable cancer denied palliative care 2Health News:Patients with advanced, incurable cancer denied palliative care 3Health News:Patients with advanced, incurable cancer denied palliative care 4Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 2Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 3Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 4
... Reporter , MONDAY, Aug. 23 (HealthDay News) -- While the ... report that the incidence of rectal cancer among people under ... young person,s chance of developing the disease remains tiny, but ... Dr. David L. Sherr, an assistant professor of radiation oncology ...
... HealthDay Reporter , MONDAY, Aug. 23 (HealthDay News) -- ... salmonella, the head of the U.S. Food and Drug Administration ... sub-recalls over the next couple of days, maybe even weeks, ... eggs that are contaminated," agency director Margaret Hamburg told NBC,s ...
... Gold Standard/Elsevier, a leading developer of drug ... launch of MEDcounselor Languages, a module that provides ... languages. The new MEDcounselor Languages will enable ... understand their drug therapy, take their medications safely, ...
... HealthDay Reporter , SUNDAY, Aug. 22 (HealthDay News) -- ... protein encoded by the BRCA2 gene. Dysfunction of this ... By separating the protein from the rest of the components ... and figure out exactly what it does in the body. ...
... while colon cancer rates have remained steady over the past ... cancer rates are increasing in this population across races and ... a peer-reviewed journal of the American Cancer Society, the study ... in young individuals who show potential signs of the disease. ...
... study of egg cells using time-lapse microscopy, researchers at ... and the Ludwig Institute for Cancer Research have discovered ... produces reproductive cells in sexually reproducing organisms. The ... cell chromosomes separate from each other may shed light ...
Cached Medicine News:Health News:Rectal Cancer Rates on the Rise in Younger Adults 2Health News:FDA Chief Says More Egg Recalls Possible 2Health News:FDA Chief Says More Egg Recalls Possible 3Health News:FDA Chief Says More Egg Recalls Possible 4Health News:Gold Standard/Elsevier promotes medication safety and compliance via New MEDcounselor languages 2Health News:Inner Workings of Gene Tied to Breast, Ovarian Cancer Revealed 2Health News:Inner Workings of Gene Tied to Breast, Ovarian Cancer Revealed 3Health News:Rectal cancer rates are rising in young individuals 2Health News:Study of cell division sheds light on special mechanism in egg cells 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: